{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Restricting Access: A Secondary Analyses of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Select the results of the study of PrEP prescribing that compares percentages of new prescriptions according to the scope of practice of the prescriber.
- Identify the results of the study.
- Choose the results of the authors? analysis of PrEP prescribing that determined variables associated with differences in prescribing rates.
Learning Outcomes
75% of participants will demonstrate knowledge of an analysis examining the association between new pre-exposure prophylaxis (PrEP) prescription fills in 2017 and state-level scope of practice laws by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
The authors report no real or perceived vested interests related to this article that could be construed as a conflict of interest.
Price:
$21.95
Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JANAC0122
Published: Jan/Feb 2022
Expires: 12/6/2024
Required Passing Score: 8/10 (80%)